#MedNews - Receiving glucocorticoids for early rheumatoid arthritis by intra-articular or intramuscular injection rather than orally could halve patients’ risk for persistent use at 1 year.

#MedNews - Receiving glucocorticoids for early rheumatoid arthritis by intra-articular or intramuscular injection rather than orally could halve patients’ risk for persistent use at 1 year.
#MedNews - Daily treatment with oral gildeuretinol acetate significantly reduces the growth rate of retinal atrophic lesions, relative to placebo, in adolescents and adults with Stargardt disease.
#MedNews - High exhaled carbon monoxide levels may be associated with a significantly decreased risk for #ParkinsonDisease in people who have never smoked, without increasing the risk for smoking-related diseases.
#MedNews - Choosing which antiseizure medications to give patients with epilepsy who are taking direct oral anticoagulant therapy is important for avoiding thromboembolic and bleeding risks.
Full story 👉️ buff.ly/D2t8wCf
From #ESCCongress 2026 - #Statin therapy significantly reduces the risk for major cardiovascular events relative to placebo in healthy adults aged 70 years or older, but disability-free survival is comparable.
From #ESCCongress 2026: The addition of low-voltage zone ablation to pulmonary vein isolation in patients with persistent atrial fibrillation significantly improves rhythm outcomes, shows the IDEAL-AF trial.
From #ESCCongress 2026: Immediate initiation of evolocumab before PCI for acute myocardial infarction leads to rapid reductions in low-density lipoprotein cholesterol, but does not improve 1-year clinical outcomes.
From #ESCCongress 2026: Beta blockers could be discontinued in stable patients with a history of MI if they have a LVEF of at least 40%, no heart failure, and no other indication for such therapy, suggests a pooled analysis.
From #ESCCongress 2026: Patients with intermediate-high-risk acute pulmonary embolism may benefit from receiving catheter-directed thrombolysis with alteplase in addition to anticoagulation therapy.
#MedNews - Serologic immunity to hepatitis A virus and hepatitis B virus is suboptimal at a population level, including among people at high risk for infection, shows a US study.